The Journal of Basic & Clinical Medical Sciences (JBCMS) proudly announces the publication of Volume 3 (2024). This issue highlights timely and significant contributions to the fields of public health, medical education, infectious diseases, pharmacotherapy, and surgical sciences, maintaining the journal’s commitment to advancing evidence-based research with relevance to clinical practice in low- and middle-income countries.
The issue opens with a Letter to the Editor by Abdullah Farooq and Taimour Mushtaq on the growing impact of three-dimensional (3D) printing in medical education. The authors emphasize how 3D-printed anatomical models are revolutionizing surgical training and anatomical understanding, particularly in resource-constrained settings. The commentary urges further integration of 3D technologies into medical curricula worldwide.
Among the original articles, Niaz Ali Khan and colleagues investigate the nutritional status of tuberculosis patients in Bhakkar, Punjab. The study reveals alarmingly high rates of malnutrition, with over one-third of patients being malnourished and more than half at risk. These findings emphasize the need for nutritional assessment and intervention as part of comprehensive TB management strategies.
In a study conducted at Khyber Medical University, Mati Ullah et al. assess knowledge, attitudes, and practices related to antibiotic use and resistance among paramedical students. Despite general awareness of antibiotics, the study uncovers frequent misuse and highlights the urgent need for enhanced training modules on antimicrobial stewardship and infection control.
Farhan Majeed and colleagues present a retrospective analysis of surgical outcomes in patients with corrosive ingestion. Their findings reveal that gender-specific patterns exist in the intent and substances ingested and that timely surgical interventions are critical in minimizing complications such as strictures and perforation.
Another pharmacovigilance-focused study by Faiqa Malik et al. evaluates the renal safety of concomitant piperacillin/tazobactam and vancomycin in pediatric cancer patients. The data suggest no significant nephrotoxicity, although the potential risk of vancomycin remains a clinical consideration.
Iram Aman Ullah and team offer a comprehensive prospective cohort study comparing clinical and patient-reported outcomes in hepatitis C patients treated with direct-acting antivirals (DAAs), with and without cirrhosis. The results show superior treatment response and quality-of-life improvements in non-cirrhotic patients, while those with cirrhosis demonstrated limited gains, signaling the need for tailored therapeutic strategies.
Collectively, the studies in this issue address critical public health concerns and contribute to advancing research, education, and clinical practice. The journal remains grateful to its editorial leadership, including Patron Dr. Naveed Akhter and Editor-in-Chief Dr. Shah Jahan, as well as to the dedicated team of reviewers and authors whose work underpins the success of each volume.
We encourage scholars, clinicians, and students to explore the current issue and submit their original research for future publication in JBCMS.
Explore Volume 3 of JBCMS: Click Here
Learn More and Submit Now: Click Here